Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Brain Cancer
Drug:
lomustine
(
Alkylating agent
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
FDA
Excerpt:
Gleostine is an alkylating drug indicated for the treatment of patients with...Brain tumors, primary and metastatic, following appropriate surgical and/or radiotherapeutic procedures.
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login